| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 541.30B | 531.62B | 510.32B | 484.46B | 481.20B | 348.18B |
| Gross Profit | 155.16B | 149.43B | 151.81B | 144.21B | 141.41B | 106.85B |
| EBITDA | 17.89B | 15.89B | 12.29B | 13.22B | 9.31B | 6.69B |
| Net Income | 7.63B | 6.03B | 7.03B | 4.67B | 2.77B | 1.99B |
Balance Sheet | ||||||
| Total Assets | 214.81B | 180.25B | 171.51B | 158.19B | 157.90B | 168.23B |
| Cash, Cash Equivalents and Short-Term Investments | 20.69B | 7.64B | 5.50B | 5.50B | 5.87B | 10.51B |
| Total Debt | 47.59B | 36.53B | 29.79B | 30.40B | 37.58B | 37.16B |
| Total Liabilities | 156.95B | 125.00B | 121.23B | 111.90B | 115.86B | 128.42B |
| Stockholders Equity | 58.08B | 55.19B | 50.18B | 46.29B | 42.04B | 39.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.82B | 2.06B | 7.33B | -7.12B | -6.49B |
| Operating Cash Flow | 0.00 | 14.43B | 14.62B | 14.53B | -777.00M | 8.97B |
| Investing Cash Flow | 0.00 | -17.35B | -11.63B | -7.38B | -4.04B | -14.88B |
| Financing Cash Flow | 0.00 | 5.06B | -3.82B | -7.51B | 172.00M | 2.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥201.65B | 12.15 | ― | 2.18% | 6.30% | 27.88% | |
73 Outperform | ¥195.24B | 16.84 | 7.56% | 2.70% | 2.28% | 3.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥181.52B | 47.61 | ― | 1.44% | 1.48% | -33.32% | |
58 Neutral | ¥100.05B | 13.10 | ― | 1.54% | 4.07% | 47.70% | |
56 Neutral | ¥126.83B | 35.28 | ― | 1.77% | 8.65% | -45.94% | |
53 Neutral | ¥177.99B | 89.65 | ― | 1.77% | 30.67% | ― |